New frontiers in assessing pain and analgesia in laboratory animals

Expert Opinion on Drug Discovery

Volumn 3, Issue 9, 2008, Pages 1099-1108

  Cortright, Daniel N ^a,b   Matson, David J ^a   Broom, Daniel C ^a  

^a NEUROGEN CORPORATION   (United States)

^b NONE   (United States)

Author keywords

Analgesics; Pain; Stimulus evoked

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; MORPHINE; OPIATE;

ANALGESIA; ANIMAL BEHAVIOR; BEHAVIOR CHANGE; BEHAVIORAL RESEARCH; CIRCADIAN RHYTHM; DRUG EFFICACY; EXPERIMENTAL ANIMAL; FEEDING BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAIT; HYPERALGESIA; LOCOMOTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PLACE PREFERENCE; PRIORITY JOURNAL; REVIEW; VOCALIZATION; WEIGHT BEARING;

EID: 52649087421     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.3.9.1099     Document Type: Review

References (86)

1. Walker K, Fox AJ, Urban LA. Animal models for pain research. Mol Med Today 1999;5(7):319-21
2. Negus SS, et al. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 2006;319(2):507-14
3. Joshi SK, Honore P. Animal models of pain for drug discovery. Expert Opin Drug Discov 2006;1(4):323-34
4. Chaplan SR, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53(1):55-63
5. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957;111(4):409-19
6. Neugebauer V, et al. Techniques for assessing knee joint pain in arthritis. Mol Pain 2007;3:8
7. Whiteside GT, Adedoyin A, Leventhal L. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 2008;54(5):767-75
8. Vierck CJ, Hansson PT, Yezierski RP. Clinical and pre-clinical pain assessment: are we measuring the same thing? Pain 2008;135(1-2):7-10
9. Song XJ, et al. Mechanical and thermal hyperalgesia and ectopic neuronal discharge after chronic compression of dorsal root ganglia. J Neurophysiol 1999;82(6):3347-58
10. Djouhri L, et al. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 2006;26(4):1281-92
11. Hill R. NK1 (substance P) receptor antagonists-why are they not analgesic in humans? Trends Pharmacol Sci 2000;21(7):244-6
12. Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids 2006;31(3):251-72
13. Chesler EJ, et al. Influences of laboratory environment on behavior. Nat Neurosci 2002;5(11):1101-2
14. Callahan BL, et al. Modulation of mechanical and thermal nociceptive sensitivity in the laboratory mouse by behavioral state. J Pain 2008;9(2):174-84
15. Langford DJ, et al. Social modulation of pain as evidence for empathy in mice. Science 2006;312(5782):1967-70
16. Loggia ML, Mogil JS, Catherine Bushnell M. Empathy hurts: compassion for another increases both sensory and affective components of pain perception. Pain 2008;136(1-2):168-76
17. Mogil JS. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA 1999;96(14):7744-51
18. Greenspan JD, et al. Studying sex and gender differences in pain and analgesia: a consensus report. Pain 2007;132(Suppl 1):S26-45
19. Woodcock JJ, et al. Stimulating the development of mechanism-based, individualized pain therapies. Nat Rev Drug Discov 2007;6(9):703-10
20. Scott DJ, et al. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 2007;55(2):325-36
21. Joshi SK, et al. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity. Neuroscience 2006;143(2):587-96
22. Petersen KL, et al. A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization. J Pain 2003;4(7):400-6
23. Frymoyer AR, et al. Placebo-controlled comparison of a morphine/ dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers. J Pain 2007;8(1):19-25
24. Bishop T, et al. Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat. Pain 2007;131(1-2):70-82
25. Gustorff B, et al. The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers. Anesth Analg 2004;98(2):401-7
26. Kraft B, et al. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology 2008;109(1):101-10
27. Keay KA, et al. Peripheral nerve injury evokes disabilities and sensory dysfunction in a subpopulation of rats: a closer model to human chronic neuropathic pain? Neurosci Lett 2004;361(1-3):188-91
28. Sufka KJ, et al. Scoring the mouse formalin test: validation study. Eur J Pain 1998;2(4):351-8
29. Wilson SG, et al. Identification of quantitative trait loci for chemical/ inflammatory nociception in mice. Pain 2002;96(3):385-91
30. Wilson SG, et al. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics. J Pharmacol Exp Ther 2003;304(2):547-59
31. Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 2004;271(10):1814-9
32. McNamara CR, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 2007;104(33):13525-30
33. Luger NM, et al. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res 2001;61(10):4038-47
34. Sevcik MA, et al. Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology 2006;131(3):900-10
35. Luger NM, et al. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 2002;99(3):397-406
36. Sabino MA, et al. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 2002;62(24):7343-9
37. Jourdan D, Ardid D, Eschalier A. Analysis of ultrasonic vocalisation does not allow chronic pain to be evaluated in rats. Pain 2002;95(1-2):165-73
38. Calvino B, et al. Ultrasonic vocalization (22-28 kHz) in a model of chronic pain, the arthritic rat: effects of analgesic drugs. Neuroreport 1996;7(2):581-4
39. Han JS, et al. Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior. J Neurosci Methods 2005;141(2):261-9
40. Hasnie FS, et al. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 2007;144(4):1495-508
41. Matson DJ, et al. Inflammation-induced reduction of spontaneous activity by adjuvant: a novel model to study the effect of analgesics in rats. J Pharmacol Exp Ther 2007;320(1):194-201
42. Sasakawa T, et al. FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: implication of distinct effect from suppression of inflammation. Int Immunopharmacol 2005;5(3):503-10
43. Millecamps M, et al. Circadian pattern of spontaneous behavior in monarthritic rats: a novel global approach to evaluation of chronic pain and treatment effectiveness. Arthritis Rheum 2005;52(11):3470-8
44. Millecamps M, et al. Decrease in non-selective, non-sustained attention induced by a chronic visceral inflammatory state as a new pain evaluation in rats. Pain 2004;109(3):214-24
45. Clayton N, et al. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 2002;96(3):253-60
46. Bove SE, et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage 2003;11(11):821-30
47. Whiteside GT, et al. Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol 2004;141(1):85-91
48. Zhu CZ, et al. Role of central and peripheral mGluR5 receptors in post-operative pain in rats. Pain 2005;114(1-2):195-202
49. Zhu CZ, et al. Analgesic activity of metabotropic glutamate receptor 1 antagonists on spontaneous post-operative pain in rats. Eur J Pharmacol 2008;580(3):314-21
50. Beyreuther BK, et al. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur J Pharmacol 2007;565(1-3):98-104
51. Bove SE, et al. Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia. Osteoarthritis Cartilage 2006;14(10):1041-8
52. Wilson AW, et al. An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models. Eur J Pain 2006;10(6):537-49
53. Kehl LJ, Trempe TM, Hargreaves KM. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 2000;85(3):333-43
54. Benoliel R, et al. Application of a pro-inflammatory agent to the orbital portion of the rat infraorbital nerve induces changes indicative of ongoing trigeminal pain. Pain 2002;99(3):567-78
55. Pomonis JD, et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005;114(3):339-46
56. Miklyaeva EI, Martens DJ, Whishaw IQ. Impairments and compensatory adjustments in spontaneous movement after unilateral dopamine depletion in rats. Brain Res 1995;681(1-2):23-40
57. Hamers FP, et al. Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma 2001;18(2):187-201
58. Clarke KA, et al. Gait analysis in a rat model of osteoarthrosis. Physiol Behav 1997;62(5):951-4
59. Coulthard P, et al. Gait analysis as an objective measure in a chronic pain model. J Neurosci Methods 2002;116(2):197-213
60. Coulthard P, Simjee SU, Pleuvry BJ. Gait analysis as a correlate of pain induced by carrageenan intraplantar injection. J Neurosci Methods 2003;128(1-2):95-102
61. Vrinten DH, Hamers FF. 'CatWalk' automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat;a comparison with von Frey testing. Pain 2003;102(1-2):203-9
62. Gabriel AF, et al. The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods 2007;163(1):9-16
63. Simjee SU, Pleuvry BJ, Coulthard P. Modulation of the gait deficit in arthritic rats by infusions of muscimol and bicuculline. Pain 2004;109(3):453-60
64. Mauderli AP, Acosta-Rua A, Vierck CJ. An operant assay of thermal pain in conscious, unrestrained rats. J Neurosci Methods 2000;97(1):19-29
65. King CD, et al. Differential effects of stress on escape and reflex responses to nociceptive thermal stimuli in the rat. Brain Res 2003;987(2):214-22
66. King CD, et al. Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience 2007;147(1):174-82
67. Vierck Q, Acosta-Rua AJ, Johnson RD. Bilateral chronic constriction of the sciatic nerve: a model of long-term cold hyperalgesia. J Pain 2005;6(8):507-17
68. Baliki M, et al. Spared nerve injury rats exhibit thermal hyperalgesia on an automated operant dynamic thermal escape task. Mol Pain 2005;1:18
69. Vierck CJ, Yezierski RP, Light AR. Long-lasting hyperalgesia and sympathetic dysregulation after formalin injection into the rat hind paw. Neuroscience 2008;153(2):501-6
70. LaBuda CJ, Fuchs PN. A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp Neurol 2000;163(2):490-4
71. LaBuda CJ, Fuchs PN. Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain. Neurosci Lett 2000;290(2):137-40
72. LaBuda CJ, Fuchs PN. Low dose aspirin attenuates escape/avoidance behavior, but does not reduce mechanical hyperalgesia in a rodent model of inflammatory pain. Neurosci Lett 2001;304(3):137-40
73. Stevenson GW, Bilsky EJ, Negus SS. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 2006;7(6):408-16
74. Martin TJ, et al. Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 2007;106(2):312-22
75. Sadzot B, Frost JJ. Pain and opiate receptors: considerations for the design of positron emission tomography studies. Anesth Prog 1990;37(2-3):113-20
76. Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 2000;30(5):263-88
77. Borsook D, Becerra LR. Breaking down the barriers: fMRI applications in pain, analgesia and analgesics. Mol Pain 2006;2:30
78. Borsook D, et al. Neuroimaging revolutionizes therapeutic approaches to chronic pain. Mol Pain 2007;3:25
79. Governo RJ, et al. Validation of an automated punctate mechanical stimuli delivery system designed for fMRI studies in rodents. J Neurosci Methods 2007;163(1):31-7
80. Lowe AS, Beech JS, Williams SC. Small animal, whole brain fMRI: innocuous and nociceptive forepaw stimulation. Neuroimage 2007;35(2):719-28
81. Moylan Governo RJ, et al. Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: a functional magnetic resonance imaging study. Pain 2006;126(1-3):35-45
82. Hess A, et al. Imaging of hyperalgesia in rats by functional MRI. Eur J Pain 2007;11(1):109-19
83. Lilja J, et al. Blood oxygenation level-dependent visualization of synaptic relay stations of sensory pathways along the neuroaxis in response to graded sensory stimulation of a limb. J Neurosci 2006;26(23):6330-6
84. Governo RJ, et al. Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study. Br J Pharmacol 2008;153(7):1558-67
85. Chin CL, et al. Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Br J Pharmacol 2008;153(2):367-79
86. Shah YB, et al. Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) 2005;180(4):761-73